Company facts
- Headquarters
- Scottsdale, Arizona
- Most recent report
- 10-Q, filed Nov 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1069183
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 44
News 8 of 122
Prospectuses and Registrations 8 of 20
- 424B5 Prospectus supplement for an offering Sep 17, 2026
- FWP Free writing prospectus Sep 16, 2026
- 424B5 Prospectus supplement for an offering Sep 15, 2026
- S-8 Registration statement for an employee plan Jun 10, 2024
- 424B5 Prospectus supplement for an offering May 13, 2024
- S-3ASR Automatic shelf registration Mar 1, 2024
- S-8 Registration statement for an employee plan Sep 23, 2022
- S-8 Registration statement for an employee plan Jul 18, 2022
Proxies 8 of 45
- DEFA14A Extra proxy material Apr 16, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2026
- DEFA14A Extra proxy material May 16, 2025
- DEFA14A Extra proxy material May 12, 2025
- DEFA14A Extra proxy material Apr 16, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2025
- DEFA14A Extra proxy material Apr 15, 2024
- DEFA14A Extra proxy material Apr 15, 2024
Ownership 8 of 740
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Sep 14, 2026
- 144 Notice of a proposed sale of restricted stock Sep 11, 2026
- 4 Insider reported a trade Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Sep 2, 2026
Other 8 of 29
- 305B2 Sep 15, 2026
- SD Conflict minerals disclosure May 28, 2026
- ARS Annual report sent to shareholders Apr 16, 2026
- SD Conflict minerals disclosure May 29, 2025
- ARS/A Annual report sent to shareholders, amended May 12, 2025
- ARS Annual report sent to shareholders Apr 16, 2025
- SD Conflict minerals disclosure May 30, 2024
- POSASR Apr 19, 2024
What to read: Sep 2026 10-Q
SECSift found 3 of 13 sections worth reading, with 1 positive, 5 notable, and 9 negative flags.
Financial Statements (Item 1)
Large debt raise, acquisitions, strategic investment, and big backlog detail.Notable- Remaining performance obligations of $10.2B as of Sept 30, 2026, with 20-25% expected in 12 months.
- Issued $1.15B 0% convertible notes due 2031 in Sept 2026, net proceeds ~$1.14B after costs and $114.9M capped calls.
- Acquired Carbyne for $551.7M cash and Prepared for $623.9M cash, adding $523M and $585M goodwill respectively.
- Post-quarter, Axon agreed to invest up to $1.2B in Skydio, increasing ownership to ~37%, with $127.5M cash paid Nov 5, 2026.
Management's Discussion (Item 2)
Revenue up 28% to $909M, but gross margin fell sharply; cash from ops only $8M; $1.2B Skydio investment ahead.Risk Factors (Item 1A)
New debt-structure risks: 2027 warrants still outstanding after note redemption, 2031 capped calls, and covenant details.Negative- 2027 Warrants still outstanding after note redemption; could dilute stock if price exceeds strike price.
- 2031 Capped Calls do not offset dilution for diluted EPS calculation, and counterparty actions could cause stock price fluctuations.
- Counterparty risk: Option Counterparties are unsecured; default could reduce benefits and increase dilution.
- Revolving credit facility requires maintaining specified financial ratios; limits on debt, liens, dividends, and asset sales.
- Conversion of 2031 Notes could require cash payments or dilute stockholders; reclassification to current liability could reduce working capital.
- Debt service may exceed cash flow; alternatives like asset sales or equity financing could be unfavorable or dilutive.
What changed: Sep 2026 vs. Jun 2026
About 17% of AXON's Sep 2026 10-Q is new information. 52 paragraphs were added, 167 changed, and 35 removed. Below are the most important lines SECSift identified.
New
- New disclosure: $1.15B of 2031 Notes outstanding, and a planned $1.2B Skydio investment.
- Added Exhibit 10.1: Form of Capped Call Confirmation.
- Added Exhibit 10.2: Amendment No. 2 dated September 15, 2026, amending the Credit Agreement dated December 15, 2022.
- Added Exhibit 4.1: Base Indenture dated September 18, 2026, between Axon and U.S. Bank Trust Company.
- Added Exhibit 4.2: First Supplemental Indenture dated September 18, 2026, between Axon and U.S. Bank Trust Company.
- Added Exhibit 4.3: Form of 0% Convertible Senior Note due 2031.
Changed
- Net income rose to $57.0M from a loss of $2.2M in Q3 2025, and to $255.7M from $121.9M in nine months.
- Available borrowing capacity increased to $490.9M from $290.9M as of Jun 30, 2026.
- Cash and cash equivalents rose to $1.46B at Sep 30, 2026 from $0.6B at Jun 30, 2026.
- Added new risk: 2027 Note Hedge, 2027 Warrant, and 2031 Capped Call transactions may impact common stock value.
- Added new risk: conversion of 2031 Notes may dilute stockholder ownership or depress stock price.
- Added new risk: counterparty risk for 2027 Note Hedge and 2031 Capped Call transactions.
- Added new risk: restrictive covenants in debt limit operational flexibility.
Everything here comes from Axon Enterprise, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 6, 2026, from the 10-Q for Sep 2026.